The Advanced Practitioner Society of Hematology and Oncology (APSHO) has launched two new educational courses for advanced practitioners in oncology care, developed in collaboration with The Hope Foundation for Cancer Research. The self-paced online courses provide practical, evidence-informed education focused on real-world clinical p...
The program will use AI-driven risk assessment, next-generation DNA testing, and personalized surveillance to identify pancreatic cancer at its earliest stages. It will also leverage world-class imaging technologies and expand access to specialized screening and prevention services.
Jennifer Frederick, an oncology clinical trial organizer at Wash U Medicine, received the 2026 Alliance Clinical Research Professionals Research Integrity Service Award for her dedication to helping cancer patients access clinical trials. Her work ensures that trials run smoothly and safely, with a focus on patient advocacy and compass...
The Alliance for Clinical Trials in Oncology is highlighting eight ongoing clinical trials focused on improving cancer detection, treatment, and survivorship for men's cancers. These trials aim to enhance quality of life and support patients and their loved ones after treatment.
Francis Peyton Rous identifies transmissible cancer agent in chickens, challenging established ideas about cancer. His discovery leads to the development of viral oncology and modern understanding of cancer as a genetic disease.
A new trial shows that a shorter three-week radiation course is as safe and effective as the standard five-week treatment for women undergoing breast reconstruction. The RT CHARM trial found no increase in complications or effects on reconstruction efforts.
The University of Texas MD Anderson Cancer Center has awarded Lakeisha Keller-Davis, RN, MSN, CMSRN, and Ellen C. Mullen, Ph.D., APRN-BC, with the 2026 Brown Foundation Award for Excellence in Oncology Nursing. The awards recognize exceptional patient care, clinical practice, leadership, and commitment to improving patient outcomes.
A recent study found that paid family and medical leave policies are widely available but inconsistently implemented across US academic radiology and radiation oncology departments. Most programs require faculty to use vacation or sick time with variable allowance, and few employees utilized leave in the previous year.
NCCN has published regional cancer treatment guidelines for the Philippines, tailored to the local setting and regulatory environment. The guidelines reflect collaborations with global organizations, including the International Gynecologic Cancer Society and the Philippine Society of Medical Oncology, to improve access to high-quality ...
Theresa Werner, MD, has been appointed chief of the Division of Oncology at Huntsman Cancer Institute, overseeing clinical, research, and educational priorities. As a nationally recognized physician-scientist, she will advance innovative cancer care and research.
A new study models C. diff transmission in oncology units, revealing that asymptomatic colonized patients are the primary source of new infections. The model provides a clearer picture of C. diff transmission events and could help inform protocols to prevent future disease transmission.
A Phase III trial found stereotactic radiosurgery (SRS) improved overall survival in patients with small cell lung cancer (SCLC) brain metastases without significant difference in neurocognitive outcomes compared to hippocampal-avoidant whole brain radiotherapy (HA-WBRT).
A Phase III trial found that delivering focused radiation therapy over three to five sessions after surgery for a large brain metastasis reduced cancer recurrence at the surgical site. Fractionated stereotactic radiosurgery also showed a trend in controlling brain metastases that had not been removed surgically. Median overall survival...
The new company will provide integrated advisory and lifecycle support services to help healthcare organizations develop and sustain successful proton therapy programs. Penn Medicine and IBA will combine their expertise to create a unique platform for delivering exceptional care to patients and building sustainable oncology programs.
A large Medicare analysis found that depression is associated with higher cancer mortality, while psychotherapy soon after diagnosis reduces cancer risk. Patients with depression had a 21% lower risk of cancer-specific mortality after receiving psychotherapy within four weeks of their diagnosis.
The NRG Oncology trial found that proton therapy did not improve overall survival or progression-free survival for patients with advanced hepatocellular carcinoma. However, fewer grade 3 or higher treatment-related adverse events were observed with proton therapy compared to photon therapy.
UCLA researchers present new radiotherapy research for prostate cancer, head and neck cancers, and personalized radiation therapy. A genetic test identifies men with prostate cancer at higher risk of urinary side effects after SBRT, suggesting personalized radiation treatment.
Studies on hypofractionated postmastectomy radiotherapy, proton therapy for hepatocellular carcinoma, and stereotactic body radiation therapy for Ewing sarcoma showcase improved patient outcomes. The findings also suggest potential benefits for short-course radiation therapy access and patient navigation in cancer centers.
Insilico Medicine will present initial Phase I data for ISM6331, a pan-TEAD inhibitor, in patients with advanced solid tumors and mesothelioma. The treatment targets the Hippo pathway, a key regulator of cell growth and survival.
Leading experts from the University of Pennsylvania School of Medicine will present research and moderate sessions on advancements in radiation oncology care and research. Neha Vapiwala, MD, will deliver the Presidential Address, highlighting priorities and insights for advancing radiotherapy's role in clinical care.
This book examines the role of heterocyclic compounds in modern anticancer drug discovery and development. It explores diverse heterocyclic scaffolds being investigated as potential anticancer agents, including pyrimidines, imidazoles, and quinolines.
The Alliance for Clinical Trials in Oncology is hosting a public webinar highlighting key findings from Alliance and Alliance Foundation Trials studies presented at the 2026 ASCO Annual Meeting. The webinar will feature treatment advances for breast, lung, and prostate cancers, and will include patient representatives to provide insigh...
The WIN 2026 Symposium will bring together experts to explore advances in precision oncology and strategies for improving personalized cancer care. The symposium, themed Precision Oncology: Innovation and Equity Across the Globe, will feature an international lineup of distinguished oncology and biomedical research leaders.
Four outstanding oncology professionals receive 2026 ESMO awards for their contributions to cancer research, clinical care, and community leadership. The awards recognize pioneering work in cancer prevention, early detection, and immunotherapy.
The Alliance for Clinical Trials in Oncology has released a film highlighting the importance of clinical trials in cancer research, featuring the story of a lung cancer patient who participated in a trial. The film emphasizes the human element of research and explores how individual participation contributes to progress in cancer care.
The BMJH Sankalp Center for Paediatric Haematology Oncology has achieved JACIE certification, a landmark milestone for haematopoietic cell transplantation and cellular therapy in India. This certification ensures safe and effective care for children with life-threatening blood disorders.
The NRG-LU005 trial found that patients receiving twice-daily radiation experienced a more favorable quality-of-life trajectory than those receiving once-daily radiation. This association remained after adjusting for patient characteristics, although the radiation schedule was not randomized.
The NRG-GU005 trial shows that SBRT improves bowel health related quality of life in localized intermediate risk prostate cancer patients, with no significant impact on urinary HRQOL. SBRT is also associated with lower incontinence related quality of life and improved maintenance of erectile dysfunction compared to hypofractionated IMRT.
NRG Oncology receives a perfect grant score of 10 and increased funding from the National Cancer Institute to continue its practice-changing clinical trials. The organization's focus on sex-specific malignancies has led to exceptional progress in cancer research.
NGR Oncology has appointed multiple new leadership members to various subcommittees, including Rebecca Arend as Gynecology Oncologist Vice Chair of the Translational Science Committee and Robin Lockhorst as Chair of the Pharmacy Subcommittee. David Miyamoto was also appointed Radiation Oncology Vice Chair of the Translational Science C...
Exercise oncology identifies anti-tumor mechanisms that can be translated into therapies independent of exercise itself. Mechanistic insights from exercise research inform translational opportunities in areas like metabolic remodeling, gut microbiome manipulation, and immune signaling.
A new study found that a virtual smoking cessation treatment program nearly doubled quit rates for cancer patients who currently smoke. The program, delivered at community oncology care settings, was both cost-effective and satisfying for patients. Participants who completed more sessions had a higher likelihood of quitting.
The study demonstrated significant clinical benefits for patients, with single treatments leading to meaningful reductions in moderate-to-severe symptoms. Patient satisfaction was exceptionally high throughout the program, with over 80% strongly agreeing they were satisfied with the services.
A nationwide analysis found that many radiation oncology clinics have closed, particularly in rural communities, reducing access to lifesaving cancer treatment. The study suggests that understanding which communities are most vulnerable can help policymakers develop strategies to preserve access.
A new study found that over 50 million Americans live in counties without a radiation oncology clinic, highlighting vulnerabilities in the nation's cancer care infrastructure. Radiation oncology practices have closed disproportionately in rural areas and freestanding settings, raising concerns about patients' access to cancer care.
Afzalbek Fayzullaev, a second-year Boston University medical student, has been awarded the ASTRO Medical Student Fellowship Award to conduct an eight-week mentored research project in radiation oncology. He aims to investigate the readability of patient education materials and their impact on treatment adherence.
Gustave Roussy and The Lancet launch a landmark international lecture series in oncology, focusing on personalised prevention. Renowned expert Professor Timothy R. Rebbeck will deliver a lecture on tailored cancer prevention strategies.
A survey of healthcare professionals revealed limited cardio-oncology training during undergraduate and postgraduate education, with only 10% reporting exposure to the subject during medical school. The study highlights the need for standardised educational programmes to address cardiovascular side effects of cancer therapies.
A meta-analysis of studies found that guideline-recommended heart failure therapies protect heart function in patients treated for cancer. RAAS inhibitors and beta-blockers improved left ventricular ejection fraction, while mineralocorticoid antagonists showed encouraging protective effects.
Terasaki Institute researchers and key pioneers publish comprehensive review on glioma organoid models, proposing a foundational classification framework to guide translational brain tumor research. The review provides an overview of human glioma organoid systems and aims to address methodological heterogeneity in the field.
Valsamo Anagnostou, Jordan Berlin, and Olisaemeka Ogbue receive ECOG-ACRIN's Young Investigator Award, Remarkable Mentor in Oncology Award, and Paul Carbone, MD Fellowship Award for outstanding contributions to translational research, mentorship, and improving cancer care. The awards are funded by the ECOG Research & Education Foundation.
Dr. Nageatte Ibrahim brings her expertise in immunotherapy and cancer drug development to HonorHealth Research Institute, focusing on advancing novel treatments and improving patient outcomes. The institute aims to develop collaborations with leading research centers worldwide to bring cutting-edge therapies to patients in need.
A Phase 3 trial showed a 56% reduction in the risk of disease progression or death for patients with BRAF V600E mutant metastatic colorectal cancer treated with a targeted therapy combination. The treatment improved median progression-free survival and overall survival, with nearly 75% of patients alive at 18 months.
The NRG Oncology trial showed a sustained overall survival benefit for patients with advanced or recurrent endometrial cancer treated with pembrolizumab and chemotherapy, even after post-study immunotherapy. The benefit persisted in both mismatch repair proficient and deficient populations.
Researchers will present over 30 studies on precision oncology, early cancer detection and AI-powered personalized care. Featured topics include biomarker-driven treatments for bladder and lung cancers, new approaches for triple-negative breast cancer and AI-enabled analysis of tumor microenvironment in colon cancer.
Dr. Sharon Giordano and Dr. Eduardo Vilar-Sanchez receive ASCO Special Awards for their transformative work in breast cancer research and prevention, respectively. Their contributions advance understanding of cancer and improve patient outcomes.
Researchers from Mount Sinai will present various studies on myelofibrosis, lung cancer, multiple myeloma, urothelial cancer, gynecologic cancers, and care innovation. Key findings include selinexor plus ruxolitinib in JAK inhibitor-naïve myelofibrosis and efficacy of HLX43 in advanced non-small cell lung cancer.
The Alliance A082402 study evaluates the effectiveness of involved-station I²-PORT in reducing NSCLC recurrence without long-term side effects. Participants will undergo randomized treatment with or without targeted radiation therapy after surgery.
The ASTRO Annual Meeting will take place in Boston from September 26-30, featuring research presentations, keynote addresses, and panel discussions on critical cancer care issues. The meeting aims to foster meaningful conversations about radiation therapy's value in advancing patient care.
The review highlights how retrieval-augmented generation can improve the accuracy, transparency, and clinical reliability of AI tools in cancer care. RAG-enhanced systems produced more accurate results than standard AI models across multiple studies.
SourceSAGE·JournalAI in Precision Oncology·TypeLiterature review·DateApr 30, 2026
Independent academic clinical trials are essential for improving patient outcomes, reducing inequalities in care, and strengthening healthcare systems. The Lancet Oncology Commission aims to deliver actionable recommendations to ensure these trials continue to benefit patients and society worldwide.
Proteomics-driven precision oncology combines multi-omics integration to reveal tumor heterogeneity and functional regulatory networks. Emerging single-cell and spatial proteomics technologies with AI analysis facilitate clinically relevant biomarker discovery.
SourceELSP·JournalAdvanced Cancer Research·TypeLiterature review·DateApr 27, 2026
The Alliance for Clinical Trials in Oncology has several active trials specifically designed to help people with head and neck cancers. Trials include testing high-dose prophylactic gabapentin to prevent opioid use during treatment, as well as immunotherapy with nivolumab and cabozantinib for mucosal melanoma and nasopharyngeal carcino...
Oncology services are often excluded from emergency health priorities, resulting in delayed diagnosis and treatment interruptions. Vulnerable populations, including women and children, face advanced disease stages due to delays in care.
A team led by Professor Julia Beatty explores how feline tumour viruses offer vital insights into human oncology and viral carcinogenesis. Domestic cat hepatitis B virus is strongly associated with feline HCC, mirroring human HBV oncogenic patterns.
A clinical trial aims to evaluate whether laser therapy reduces vaginal dryness caused by breast cancer treatment. The study, REVITALIZE, plans to enroll approximately 250 women with a history of breast cancer who experience moderate to severe vaginal dryness.
Nancy L. Lewis, MD, MBS, FACP, a renowned biomedical researcher and clinical trials expert, has been appointed as the new Chief Scientific Officer of the National Comprehensive Cancer Network (NCCN). She will oversee NCCN's programs to advance clinical trials and improve cancer care outcomes globally.
A new article in JMIR Publications showcases precision oncology's success, where individualized multi-drug regimens improve treatment responses and survival rates for patients with advanced cancers. The study found that closely matching drug therapies to tumor mutations leads to better outcomes, while also offering a safer profile.
NRG Oncology has appointed Dr. John Nakayama as Vice Chair of the NRG Ancillary Projects Committee, Dr. Ibrahim Nassour as Vice Chair of the Surgical Oncology Committee, and Dr. Scott Okuno as Vice Chair of the Sarcoma Subcommittee. Dr. Angeles Alvarez Secord was also appointed Chair of the Investigator & Career Development Committee.
Dr. Lisa G. Roth, MD has joined Hassenfeld Children’s Hospital at NYU Langone and Perlmutter Cancer Center as director of the Division of Pediatric Hematology-Oncology. She will oversee clinical care, research, and education programs while expanding access to advanced therapies and clinical trials.